Should you average down? What to check before adding to a falling stock

Understand what the arithmetic changes#

Suppose you bought 100 shares at $20 and later bought 100 at $10. Ignoring fees and taxes, the total cost is $3,000 for 200 shares, or $15 each. At a $10 market price, the position is worth $2,000 and the unrealised loss is $1,000.

The additional purchase did not erase the original dollar loss at that moment. It increased the number of shares exposed to future price changes. A return to your new average is still not guaranteed.

If the price then fell to $5, the 200 shares would be worth $1,000 against the $3,000 cost. That scenario illustrates exposure, not a prediction. Lowering the average cost is an accounting result; improving the prospective investment case requires separate evidence.

Ask what changed in the company#

Reopen the reason you first researched it. Compare the latest revenue, margins, cash flow, debt terms and share count with the old record. Look for new customer losses, financing needs or changes to the competitive position.

Do not assume the absence of an obvious headline means nothing changed. Equally, do not invent a business explanation for every price move. Keep verified disclosures and possible explanations separate. Use the falling-stock checklist.

Revalue from today's evidence#

A lower price can make the same business more attractive, but the business may no longer be the same proposition. If estimated sustainable earnings fell faster than the share price, a familiar valuation ratio might not have become cheaper.

Check the denominator and the financing assumptions. A company that needs new equity or expensive refinancing may have a different per-share outlook even if its product remains useful. Your original purchase price is not an input that determines current business value.

Examine the larger position#

Adding increases exposure to company-specific risks and may increase exposure to an industry you already own through other investments. Consider how the position relates to the rest of the portfolio, including funds with overlapping holdings.

FINRA's concentration guidance explains why apparently separate holdings can share risks. No universal percentage makes every concentrated position appropriate.

Write the reason before changing the position#

Try a short research note: what new evidence supports the business, how the current valuation differs, what remains uncertain and what a weaker outcome would mean. If the only reason is “I want to get back to even,” the company case has not been updated.

An unresolved financing issue may justify more research rather than another purchase. A new report may strengthen the evidence without settling personal suitability. The relevant choice is not automatically between buying more and admitting failure.